PARS - Pharmos Corp - Page 5

^ Where did you get this info? I was looking for such a tool..

I believe that's his personal account info from Sharebuilder. He's just showing the purchases he personally made.

I thought it was a script that showed buys vs sells? Blond moment.

Symbol Description Market Value1 Value % Trade
PARS PHARMOS CORPORATION $6,145.00 94.7 % Buy | Sell
BDMXX MONEY MARKET CASH $328.26 5.1 %


Recent Transactions Date Action Description Symbol Quantity Amount
1/13/2009 BUY ORDER POSTING PARS 2385.0000 -$320.00
1/13/2009 BUY ORDER POSTING PARS 8400.0000 -$1,117.58
1/13/2009 BUY ORDER POSTING PARS 5400.0000 -$719.00
1/13/2009 BUY ORDER POSTING PARS 9700.0000 -$1,292.36
1/13/2009 BUY ORDER POSTING PARS 4226.0000 -$476.48
View / download transactions


See! I totally BELIEVE in PARS!!!



Yep, this is from my sharebuilder account.
Just wanted to let people know that I bought when they did and at the same price of .13 cents.

I totally expect to sell in the .20's or higher. Higher if news comes out.

That's okay. I just knew because I also use Sharebuilder and am familiar with their display format.

Okay, I'm going to try the lazy approach here.

In a nutshell, tell me why I should buy this, what I should realistically expect, when and why?? I have some settles coming tomorrow a.m. and will consider 100k shares of this.

i use sharebuilder also ,,

nice and easy to use

First and foremost make sure to do your own research and make sure you feel comfortable buying PARS.

Here are some reasons.

My new pick is PARS - Pharmos Corp.

I seen that #1 picker made a comment about this one a few days ago on HSM.

This stock is great for many reasons.

1. Pharmas are hot

2. The price is very low and you can accumulate many shares for not too much money.

3. It is currently not too far off of it's 52 week low, this is a very good thing.

4. They recently had a bad outing with a drug, this doesn't sound like good news, but I will explain why it is. Because now they are giving complete focus on their phase II irritable bowel drug wich they feel very strongly about.

5. Prior insider transactions, insiders paid much hire for this stock in august of 2008, trust me.. They want their money back at least, if not more.

6. Any decent news will make this stock double.

7. No news at all may make this stock double.

8. PARS trades on the NASDAQ!

9. Did I mention that Pharmas are HOT!?

10. We are getting in cheap before many people know.

11. Extremely low float, so beware when buying at market, unless you want to pay .20 cents a share.

12. Strong hands own PARS, they are not selling easily whatsoever.

There are other good reasons too, like this is a buyout candidate, or they
could pick up a partner for one of their drugs in their pipeline.

Pricey though. Can't buy most OTC stocks, large order surcharge, and can't buy and sell past the .01 increment.

JWS, prior page has some reasons.

By the way, we here hope that you get in at bid, I know people will think I am nuts for saying this, but do not pay the ask.

This is not a pump and dump of any kind, we DO NOT CARE to see the price inflated, we just want to see the volume come in.

Get in as cheap as you can, even if at .12 cents.

I honestly don't think anyone will sell at that, but I bet you can get your 100,000 for what the rest of us paid, .13 cents.

*
PHARMOS CORP Profile

Drug developer Pharmos has focused its attention on the central nervous system. Its stable of drug candidates aim to treat conditions such as pain, inflammation, and autoimmune conditions. It gained its lead candidate dextofisopam in 2006 when it acquired Vela Pharmaceuticals; the compound is a potential treatment for irritable bowel syndrome, a condition associated with the "brain-gut axis," or the connection between the nervous system and the intestines. Pharmos has also discovered several compounds in-house using its expertise in cannabinoid compounds (the kind without psychotropic effects). It is investigating several such compounds as treatments for pain and inflammation.

S. Colin Neill, CPA
CEO

99 Wood Ave. South, Ste. 311
Iselin, NJ 08830
http://www.pharmoscorp.com
Phone: 732-452-9556
Fax: 732-452-9557

They really seem to be gung ho about their drug Dextofisopam.

Any good news on this one and we are going to see a POP!

Thanks for the input. Assuming everything settles as I expect tomorrow, I'll probably try to get in around 12.5. Not looking at much else until next week, so this looks good. I researched the basics, but like to hear other's thoughts/angles that I may not have thought of.

Newbie here... Looking to get in tomorrow for comparatively few shares, just to test the waters. I've done my bit of research and think I'm going to get on board with this one, but I haven't fully committed yet. A lot of people seem to support this stock in the long haul, but I'm looking for some short term gains so I can unload it quickly.

Anyone have any information that may correlate to this stock going up some time the future? How long until it runs?

Nobody knows, were hoping to see it hit .20-.25 soon

In for 12,500 shares at .13

is this your 1st stock you are buying ?

When is this being DELISTED?

I see no reply on nasdaqs warning.

is that question pertinent to anything?

He wanted to throw him a de-virgining party...

lol